January 26, 2011 – An enhanced coding issue management capability has been introduced. The Qualitative Intelligence and Communications System (QICS), by peerVue, is designed to streamline inter- and cross-department coding workflow to ensure that radiology departments fully capture appropriate imaging revenues.

Manufacturing costs will always be a paramount consideration in producing products, as indicated by the enormous number of goods sent offshore for manufacturing by U.S. companies and many others.

January 25, 2011 — Royal Philips Electronics has announced CE marking for the industry’s first commercially available whole-body positron emission tomography/magnetic resonance (PET/MR) imaging system, the Ingenuity TF PET/MR. The system is pending 510(k) and not available for sale in the U.S.

January 24, 2011 – Lantheus Medical Imaging has entered into a contract with Novation for Ablavar (gadofosveset trisodium) and Definity Vial for Injectable Suspension (Perflutren Lipid Microsphere). The agreement will provide increased access to the diagnostic imaging agents for healthcare providers served by Novation.

January 24, 2011 – A medical picture archiving and communication system (PACS) is now compatible with Apple’s smart phones, portable tablets and other devices. The system, by New Mexico Software, is available on the Apple App Store.

It is part of the company’s effort to engineer mobile medical applications for Apple’s iOS and Google’s Android “Honeycomb” operating systems.

January 24, 2011 – New specimen X-ray software works with an algorithm to synthesize the ability of the human eye to locate information and analyze structures within the image. The result is digital mammography quality images with a digital radiography (DR) system.

The microbubbles that make up the ultrasound contrast agent Optison.

Contrast-enhanced ultrasound (CEUS) can "dramatically improve" physicians' ability to detect heart disease and stratify future risk, said Thomas Porter, M.D., at the 16th European Symposium on Ultrasound Contrast Imaging in Rotterdam.

January 24, 2011 – A U.S. Food and Drug Administration’s (FDA) panel voted unanimously last week to recommend the clearance of a magnetic resonance imaging (MRI) contrast agent to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system (CNS).

January 21, 2011 – The U.S. Food and Drug Administration (FDA) this week unveiled a plan containing 25 actions it intends to implement during 2011 to improve its 510(k) review of medical technology, the most common path to market for medical devices.

January 21, 2011 – Intravascular ultrasound (IVUS) enabled physicians to more accurately assess the risk of individual blockages than the use of the current standard of angiographic imaging alone, according to a new study.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now